Taki Chemical Co., Ltd. (JP:4025)
:4025
Top Page
Taki Chemical Co., Ltd.
(4025)
Select Model
Select Model
Rating:77Outperform
Price Target:
¥4,813.00
▲(25.83% Upside)
Action:ReiteratedDate:04/01/26
The score is driven primarily by improving profitability and a very low-debt balance sheet, supported by a low P/E valuation. Offsetting factors are inconsistent cash-flow generation and technically overbought momentum signals that raise near-term downside risk.
Positive Factors
Margin Improvement
Sustained expansion in gross and net margins indicates better pricing, cost control, and operating leverage. Higher margins (and an EBIT margin ~10.5% in 2025) strengthen structural profitability and improve the company's ability to fund capex, dividends, and reinvestment over the medium term.
Negative Factors
Volatile Cash Generation
Irregular free cash flow and year-to-year swings in operating cash flow reduce the company's ability to consistently fund capex, dividends, or strategic M&A from internal sources. Low cash conversion (FCF ~32% of net income in 2025) raises reliance on external funding when investments are needed.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin Improvement
Sustained expansion in gross and net margins indicates better pricing, cost control, and operating leverage. Higher margins (and an EBIT margin ~10.5% in 2025) strengthen structural profitability and improve the company's ability to fund capex, dividends, and reinvestment over the medium term.
Read all positive factors
Taki Chemical Co., Ltd. (4025) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥38.60B
Dividend Yield0.13%
Average Volume (3M)21.41K
Price to Earnings (P/E)6.0
Beta (1Y)0.69
Revenue Growth9.78%
EPS Growth40.00%
CountryJP
Employees604
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)160.57
Shares Outstanding9,458,768
10 Day Avg. Volume16,570
30 Day Avg. Volume21,413
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)0.75
Price to Sales (P/S)0.77
P/FCF Ratio43.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Taki Chemical Co., Ltd. Business Overview & Revenue Model
Company Description
Taki Chemical Co., Ltd. engages in the agri, chemicals, and real estate businesses in Japan. The company offers fertilizers and soil conditioners. It also provides water treatment chemicals, including polyaluminum chloride for drinking and industr...
How the Company Makes Money
null...
Taki Chemical Co., Ltd. Financial Statement Overview
Summary
Income Statement
76
Positive
Balance Sheet
88
Very Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.36B | 41.98B | 38.92B | 34.85B | 35.85B | 32.81B |
| Gross Profit | 9.80B | 10.24B | 8.74B | 6.74B | 8.61B | 8.44B |
| EBITDA | 4.49B | 4.53B | 3.91B | 2.06B | 4.03B | 3.85B |
| Net Income | 2.68B | 3.28B | 2.30B | 1.36B | 2.06B | 1.92B |
Balance Sheet | ||||||
| Total Assets | 60.66B | 65.65B | 58.40B | 51.30B | 50.32B | 46.04B |
| Cash, Cash Equivalents and Short-Term Investments | 5.72B | 7.37B | 7.46B | 5.08B | 6.26B | 6.53B |
| Total Debt | 1.35B | 1.26B | 1.22B | 1.15B | 1.24B | 1.34B |
| Total Liabilities | 21.18B | 22.32B | 20.44B | 17.40B | 18.26B | 16.66B |
| Stockholders Equity | 39.05B | 42.89B | 37.88B | 33.82B | 31.95B | 29.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 748.00M | 2.53B | -529.00M | -34.00M | 218.00M |
| Operating Cash Flow | 0.00 | 2.31B | 4.34B | 1.62B | 1.44B | 2.82B |
| Investing Cash Flow | 0.00 | -1.06B | -1.61B | -1.64B | -1.08B | -2.32B |
| Financing Cash Flow | 0.00 | -1.46B | -352.00M | -1.17B | -543.00M | -498.00M |
Taki Chemical Co., Ltd. Technical Analysis
Positive
3825.00
Price Trends
4130.50
Positive
3941.09
Positive
3652.65
Positive
Market Momentum
104.13
Positive
52.11
Neutral
22.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4025, the sentiment is Positive. The current price of 3825 is below the 20-day moving average (MA) of 4547.00, below the 50-day MA of 4130.50, and above the 200-day MA of 3652.65, indicating a neutral trend. The MACD of 104.13 indicates Positive momentum. The RSI at 52.11 is Neutral, neither overbought nor oversold. The STOCH value of 22.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4025.
Taki Chemical Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥38.60B | 5.95 | ― | 0.13% | 9.78% | 40.00% | |
76 Outperform | ¥41.58B | 5.81 | ― | 3.53% | -3.45% | 30.52% | |
72 Outperform | ¥14.25B | 9.40 | ― | 1.81% | 9.07% | ― | |
71 Outperform | ¥33.12B | 15.24 | ― | 3.45% | 4.17% | 23.25% | |
66 Neutral | ¥26.20B | 10.33 | ― | 3.53% | 6.99% | -0.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥10.93B | 15.26 | ― | 1.06% | -9.63% | -1.71% |
* Basic Materials Sector Average
JP:4025
Taki Chemical Co., Ltd.
4,460.00
1,442.51
47.80%
JP:4366
Daito Chemix Corporation
430.00
250.07
138.99%
JP:4463
Nicca Chemical Co., Ltd.
1,662.00
425.10
34.37%
JP:4960
Chemipro Kasei Kaisya,Ltd.
665.00
381.14
134.27%
JP:5013
Yushiro Chemical Industry Co., Ltd.
3,055.00
1,295.45
73.62%
JP:7925
Maezawa Kasei Industries Co., Ltd.
2,234.00
553.80
32.96%
Taki Chemical Co., Ltd. Corporate Events
Taki Chemical to Grant Restricted Treasury Shares as Executive Compensation
Mar 26, 2026
Taki Chemical Co., Ltd. has approved the disposal of 9,072 treasury shares as advance-issue-type restricted stock compensation to five directors and nine executive and associate executive officers, at a price of ¥4,820 per share for a total o...
Taki Chemical Raises 2028 Medium-Term Plan Targets on Strong Performance
Feb 9, 2026
Taki Chemical has revised the final-year targets of its Medium-Term Management Plan 2028, lifting net sales guidance from ¥42 billion to ¥44 billion and operating profit from ¥3 billion to ¥3.5 billion, while raising its return...
Taki Chemical Raises 2028 Targets and Steps Up Investor Outreach to Close Valuation Gap
Feb 9, 2026
Taki Chemical Co. has updated its capital- and stock-price-conscious management policies after achieving record-high profits in fiscal 2025, driven by higher sales volumes in fertilizers and water treatment chemicals and robust demand for high-pur...
Taki Chemical Details 2025 Results and Progress on Medium-Term Plan 2028
Feb 9, 2026
Taki Chemical Co., Ltd. released supplementary materials on its consolidated financial results for the fiscal year ended December 31, 2025, detailing earnings performance, segment results, balance sheet data and cash flow trends. The disclosure al...
Taki Chemical Delivers Strong 2025 Earnings but Guides Lower Profit for 2026
Feb 9, 2026
Taki Chemical reported solid results for the fiscal year ended December 31, 2025, with revenue rising 7.9% year on year to ¥41.98 billion and operating profit up 18.6% to ¥3.16 billion. Profit attributable to owners of the parent jumped ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.